Showing results (71-80 of 346) with videos related to
Sort By:
Pageof 35
Expert Opinion on Drug Metabolism & Toxicology|October 28, 2014
Pharmacokinetic and pharmacodynamic evaluation of ceftaroline fosamilAndrew Merker, Larry H Danziger, Keith A Rodvold, et al.Clinical Pharmacokinetics|November 28, 2019
Omadacycline: A Review of the Clinical Pharmacokinetics and PharmacodynamicsKeith A Rodvold, Rodrigo M Burgos, Xing Tan, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 26, 2005
Daptomycin: a novel cyclic lipopeptide antimicrobialChristopher A Schriever, Cristina Fernández, Keith A Rodvold, et al.Advanced Drug Delivery Reviews|June 10, 2014
Innovative approaches to optimizing the delivery of vancomycin in individual patientsManjunath P Pai, Michael Neely, Keith A Rodvold, et al.Pathogens (Basel, Switzerland)|June 26, 2024
Improving Outcomes in Nosocomial Pneumonia: Recent Evidence and More ChallengesIhab H Masri, Bethany Busack, Andrew F ShorrCurrent Opinion in Infectious Diseases|October 7, 2022
Novel agents in development for multidrug-resistant Gram-negative infections: potential new options facing multiple challengesRadhika Arya, Breanna S Goldner, Andrew F ShorrBiomedicines|March 28, 2024
At the Intersection of Critical Care and Infectious Diseases: The Year in ReviewSarah R Sabo, Aarthi Venkatramanan, Andrew F ShorrCritical Care (London, England)|June 24, 2009
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulationMarya D Zilberberg, Smita Kothari, Andrew F ShorrInfection Control and Hospital Epidemiology|June 23, 2009
Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumoniaAndrew F Shorr, Marya D Zilberberg, Marin KollefThe Journal of Antimicrobial Chemotherapy|October 1, 2005
Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studiesAndrew F Shorr, Mark J Kunkel, Marin KollefPageof 35